KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to 19.52%.

  • Staar Surgical's EBITDA Margin rose 131000.0% to 19.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 41.97%, marking a year-over-year decrease of 495100.0%. This contributed to the annual value of 4.02% for FY2024, which is 127300.0% down from last year.
  • Per Staar Surgical's latest filing, its EBITDA Margin stood at 19.52% for Q3 2025, which was up 131000.0% from 67.61% recorded in Q2 2025.
  • Staar Surgical's 5-year EBITDA Margin high stood at 20.99% for Q3 2022, and its period low was 134.78% during Q1 2025.
  • In the last 5 years, Staar Surgical's EBITDA Margin had a median value of 10.67% in 2023 and averaged 3.92%.
  • Per our database at Business Quant, Staar Surgical's EBITDA Margin surged by 200700bps in 2021 and then tumbled by -1318300bps in 2025.
  • Quarter analysis of 5 years shows Staar Surgical's EBITDA Margin stood at 12.51% in 2021, then plummeted by -88bps to 1.51% in 2022, then soared by 806bps to 13.64% in 2023, then tumbled by -518bps to 57.02% in 2024, then surged by 134bps to 19.52% in 2025.
  • Its last three reported values are 19.52% in Q3 2025, 67.61% for Q2 2025, and 134.78% during Q1 2025.